JW홀딩스
No insider purchase over the last 90 days. The latest was filed 03 Jul 2026.
This page follows insider dealings at JW Holdings Corporation as filed with DART (FSS), a company from the Health Care sector. 3 insiders have disclosed 8 filings since 18 October 2025.
Every open-market trade in the period is a purchase: 5 purchases, from 2 insiders, and not a single sale. The totals exclude 5 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 1 major shareholder.
The latest purchase dates back some time: it was published 107 days ago, on 3 July 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. The shorter that gap, the sooner other investors can see what insiders have done.
Across the 2,648 companies tracked on its exchange, the median is 7 filings; at 8 filings, this issuer sits above that mark. The full history, which starts in 2021, counts 43 purchases against no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 53 declarations
JW홀딩스 is a company in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and commercialization of pharmaceutical products.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days (filings published 22 July 2026 to 7 October 2026): no open-market purchase or sale filed by an insider. 3 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 13 October 2026 (UTC)